21EL-642 On-Demand eCast: Donor Hemovigilance During the COVID-19 Pandemic
Tracking # 20-845515
Course overview
Ensuring donor safety is of paramount importance to our community. During this program, the speakers will share results from the recently conducted COVID-19 Convalescent Plasma (CCP) Donor Hemovigilance Multicenter Study. The study was conducted to evaluate the safety of CCP donation and to determine whether CCP donors have a higher incidence of donor adverse events (DAE) compared to conventional plasma donors. In addition, the speakers will provide an overview of the responses made by blood centers during the COVID-19 pandemic to ensure donor safety, develop CCP programs, discuss their approach to winding down the CCP collections, and strategies for converting first-time CCP donors to the regular donor pool.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technician
Public Health Technologist
Disclosure statements
Disclosures for the program faculty are provided at the beginning of the program.